SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain ...Middle East

SOPHiA GENETICS and AstraZeneca Spain expand HRD testing program to support molecular diagnosis of ovarian cancer in Spain BOSTON and ROLLE, Switzerland and MADRID, Feb. 7, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven...

Hence then, the article about sophia genetics and astrazeneca spain commit to increasing ovarian cancer testing in spain was published today ( Wednesday 07/02/2024 - 02:53 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain )

Also on site :

• Sixième sommet mondial des installateurs de Huawei : rassemblement des meilleurs installateurs afin d'intégrer les opportunités offertes par les énergies renouvelables à l'ère de l'IA
• Haier celebra la excelencia en París con su nueva gama de productos para el hogar inteligente
• L'essor de l'embauche des « New-Collar » : L'expérience l'emporte sur les diplômes, selon un rapport de SOFTSWISS-Pentasia